Search

ProsTIC clinical trials currently open LuCAB: Cabazitaxel in combination with 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A Phase I/II study ... Read more

ProsTIC is the result of a vision from the Prostate Cancer Foundation. We aim to accelerate clinical trials and research in prostate cancer to facilitate better health outcomes for men. The additional support we receive from... Read more

2024 Preceptorship: PSMA Theranostics: Precision Oncology in Practice We are thrilled to announce our 2024 ProsTIC Preceptorship: Precision Oncology in Practice to be held on the 14-16th of March.  This immersive,... Read more

ProsTIC Leadership Team Professor Michael Hofman - Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC); Nuclear Medicine and Molecular Imaging Physician  Professor Declan Murphy - Director... Read more

Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC) YouTube TV Channel   ACS Landmark Presentation at MGH  LuPSMA: The Newest Treatment Class for Advanced Prostate Cancer  Saul Hertz... Read more

Read through the following Frequently Asked Questions about PSMA theranostics: I need Lutetium PSMA treatment – can I come to Peter Mac? The... Read more